Skip to main content
. 2016 Sep 26;7(44):71548–71555. doi: 10.18632/oncotarget.12250

Table 1. Characteristics of the matched study population in the primary analysis.

Group A: with IGRT Group B: without IGRT
number (%)# or mean (SD)# number (%)# or mean (SD)# Standardized difference (rounded)
Age < 65 334 (77.14) 331 (76.44) 0.016
≥ 65 99 (22.86) 102 (23.56)
Gender female 17 (3.93) 16 (3.7) 0.012
male 416 (96.07) 417 (96.3)
Residency non-north 295 (68.13) 290 (66.97) 0.025
north 138 (31.87) 143 (33.03)
T-stage T1–T2 71 (16.4) 71 (16.4) 0
T3–T4 362 (83.6) 362 (83.6)
N-stage positive 392 (90.53) 393 (90.76) 0.008
negative 41 (9.47) 40 (9.24)
RT delivery 3DCRT 7 (1.62) 6 (1.39) 0.019
IMRT 426 (98.38) 427 (98.61)
Institution high-volume 223 (51.5) 226 (52.19) 0.014
low-volume 210 (48.5) 207 (47.81)
Period 2008–2009 40 (9.24) 40 (9.24) 0
2010–2013 393 (90.76) 393 (90.76)

Abbreviations:

#

rounded to the second decimal place;

IGRT, image-guided RT; 3DCRT, 3D conformal RT; IMRT, intensity-modulated RT; SD, standard deviation.